Press coverage about MedEquities Realty Trust (NYSE:MRT) has been trending positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. MedEquities Realty Trust earned a media sentiment score of 0.25 on Accern’s scale. Accern also gave media stories about the financial services provider an impact score of 46.0953634619543 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:
A number of equities analysts have recently issued reports on MRT shares. B. Riley reissued a “buy” rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 1st. Capital One Financial started coverage on MedEquities Realty Trust in a research report on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price target on the stock. Zacks Investment Research cut MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. KeyCorp set a $13.00 price objective on MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Sunday, October 29th. Finally, ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research note on Friday, December 1st. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. MedEquities Realty Trust presently has an average rating of “Buy” and an average price target of $13.00.
Shares of MedEquities Realty Trust (NYSE MRT) traded down $0.01 during trading hours on Wednesday, hitting $10.63. The stock had a trading volume of 168,197 shares, compared to its average volume of 155,239. MedEquities Realty Trust has a 1 year low of $10.06 and a 1 year high of $13.06. The stock has a market capitalization of $338.20, a PE ratio of 26.58 and a beta of -0.73.
The business also recently announced a quarterly dividend, which will be paid on Monday, March 5th. Investors of record on Monday, February 19th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 7.90%. The ex-dividend date of this dividend is Thursday, February 15th. MedEquities Realty Trust’s dividend payout ratio (DPR) is 210.01%.
In other MedEquities Realty Trust news, Director Randy L. Churchey acquired 5,300 shares of the company’s stock in a transaction on Monday, November 20th. The shares were bought at an average cost of $10.87 per share, with a total value of $57,611.00. Following the completion of the acquisition, the director now owns 46,776 shares in the company, valued at $508,455.12. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John W. Mcroberts purchased 18,000 shares of the stock in a transaction dated Friday, November 17th. The stock was purchased at an average cost of $10.74 per share, for a total transaction of $193,320.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 23,600 shares of company stock worth $254,129. 2.50% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “MedEquities Realty Trust (NYSE:MRT) Earns Daily Coverage Optimism Rating of 0.25” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/medequities-realty-trust-mrt-receiving-positive-press-coverage-study-shows.html.
About MedEquities Realty Trust
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.